The Role of Anti-Müllerian Hormone in Ovarian Function

Abstract

Anti-Müllerian hormone (AMH) is a member of the transforming growth factor β (TGFβ) superfamily, whose actions are restricted to the endocrine-reproductive system. Initially known for its role in male sex differentiation, AMH plays a role in the ovary, acting as a gatekeeper in folliculogenesis by regulating the rate of recruitment and growth of follicles. In the ovary, AMH is predominantly expressed by granulosa cells of preantral and antral follicles (i.e., post primordial follicle recruitment and prior to follicle-stimulating hormone (FSH) selection). AMH signals through a BMP-like signaling pathway in a manner distinct from other TGFβ family members. In this review, the latest insights in AMH processing, signaling, its regulation of spatial and temporal expression pattern, and functioning in folliculogenesis are summarized. In addition, effects of AMH variants on ovarian function are reviewed.

Keywords

anti-Müllerian hormone - folliculogenesis - signaling - genetics

Publication History

Article published online:
23 May 2024

• References

• 1 Massagué J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14 (06) 627-644
• 2 Pangas SA. Regulation of the ovarian reserve by members of the transforming growth factor beta family. Mol Reprod Dev 2012; 79 (10) 666-679
• 3 Lee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993; 14 (02) 152-164
• 4 Tran D, Muesy-Dessole N, Josso N. Anti-Müllerian hormone is a functional marker of foetal Sertoli cells. Nature 1977; 269 (5627) 411-412
• 5 Josso N, Lamarre I, Picard JY. et al. Anti-Müllerian hormone in early human development. Early Hum Dev 1993; 33 (02) 91-99
• 6 Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab 2020; 105 (11) 3361-3373
• 7 Teede HJ, Tay CT, Laven JJE. et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2023; 108 (10) 2447-2469
• 8 Cohen-Haguenauer O, Picard JY, Mattéi MG. et al. Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987; 44 (01) 2-6
• 9 Cate RL, Mattaliano RJ, Hession C. et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986; 45 (05) 685-698
• 10 Nachtigal MW, Ingraham HA. Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc Natl Acad Sci U S A 1996; 93 (15) 7711-7716
• 11 Pepinsky RB, Sinclair LK, Chow EP. et al. Proteolytic processing of Mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J Biol Chem 1988; 263 (35) 18961-18964
• 12 Massagué J. Transforming growth factor-alpha. A model for membrane-anchored growth factors. J Biol Chem 1990; 265 (35) 21393-21396
• 13 Belville C, Van Vlijmen H, Ehrenfels C. et al. Mutations of the anti-Mullerian hormone gene in patients with persistent Mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol 2004; 18 (03) 708-721
• 14 Wilson CA, di Clemente N, Ehrenfels C. et al. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily. Mol Endocrinol 1993; 7 (02) 247-257
• 15 Ingraham HA, Hirokawa Y, Roberts LM. et al. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction. Recent Prog Horm Res 2000; 55: 53-67 , discussion 67–68
• 16 Meng L, McLuskey A, Dunaif A, Visser JA. Functional analysis of rare anti-Müllerian hormone protein-altering variants identified in women with PCOS. Mol Hum Reprod 2023; 29 (05) gaad011
• 17 Stocker WA, Howard JA, Maskey S. et al. Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity. FASEB J 2024; 38 (01) e23377
• 18 Cui Y, Hackenmiller R, Berg L. et al. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev 2001; 15 (21) 2797-2802
• 19 Kurian MS, de la Cuesta RS, Waneck GL, MacLaughlin DT, Manganaro TF, Donahoe PK. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo. Clin Cancer Res 1995; 1 (03) 343-349
• 20 Mamsen LS, Petersen TS, Jeppesen JV. et al. Proteolytic processing of anti-Müllerian hormone differs between human fetal testes and adult ovaries. Mol Hum Reprod 2015; 21 (07) 571-582
• 21 Wissing ML, Mikkelsen AL, Kumar A. et al. Associations of different molecular forms of AntiMüllerian hormone and biomarkers of polycystic ovary syndrome and normal women. Fertil Steril 2019; 112 (01) 149-155.e1
• 22 Peigné M, Pigny P, Pankhurst MW. et al. The proportion of cleaved anti-Müllerian hormone is higher in serum but not follicular fluid of obese women independently of polycystic ovary syndrome. Reprod Biomed Online 2020; 41 (06) 1112-1121
• 23 Swärd P, Rosengren BE, Jehpsson L, Karlsson MK. Association between circulating furin levels, obesity and pro-inflammatory markers in children. Acta Paediatr 2021; 110 (06) 1863-1868
• 24 Sanchez VC, Goldstein J, Stuart RC. et al. Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. J Clin Invest 2004; 114 (03) 357-369
• 25 Pierre A, Racine C, Rey RA. et al. Most cleaved anti-Müllerian hormone binds its receptor in human follicular fluid but little is competent in serum. J Clin Endocrinol Metab 2016; 101 (12) 4618-4627
• 26 Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999; 13 (15) 2105-2124
• 27 Arango NA, Lovell-Badge R, Behringer RR. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999; 99 (04) 409-419
• 28 Mishina Y, Rey R, Finegold MJ. et al. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996; 10 (20) 2577-2587
• 29 van As C, Koedam M, McLuskey A. et al. Loss of anti-Müllerian hormone signaling in mice affects trabecular bone mass in a sex- and age-dependent manner. Endocrinology 2022; 163 (11) bqac157
• 30 Mishina Y, Whitworth DJ, Racine C, Behringer RR. High specificity of Müllerian-inhibiting substance signaling in vivo. Endocrinology 1999; 140 (05) 2084-2088
• 31 Visser JA. AMH signaling: from receptor to target gene. Mol Cell Endocrinol 2003; 211 (1-2): 65-73
• 32 di Clemente N, Wilson C, Faure E. et al. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 1994; 8 (08) 1006-1020
• 33 di Clemente N, Jamin SP, Lugovskoy A. et al. Processing of anti-Mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Mol Endocrinol 2010; 24 (11) 2193-2206
• 34 Cate RL, di Clemente N, Racine C, Groome NP, Pepinsky RB, Whitty A. The anti-Müllerian hormone prodomain is displaced from the hormone/prodomain complex upon bivalent binding to the hormone receptor. J Biol Chem 2022; 298 (01) 101429
• 35 Hart KN, Stocker WA, Nagykery NG. et al. Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-β family. Proc Natl Acad Sci U S A 2021; 118 (26) e2104809118
• 36 Rajpert-De Meyts E, Jørgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84 (10) 3836-3844
• 37 Durlinger AL, Gruijters MJ, Kramer P. et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002; 143 (03) 1076-1084
• 38 Huhtaniemi I, Hovatta O, La Marca A. et al. Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency. Trends Endocrinol Metab 2018; 29 (06) 400-419
• 39 Andersen CY, Byskov AG. Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab 2006; 91 (10) 4064-4069
• 40 Baarends WM, Uilenbroek JT, Kramer P. et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995; 136 (11) 4951-4962
• 41 Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002; 124 (05) 601-609
• 42 Kedem A, Yung Y, Yerushalmi GM. et al. Anti Müllerian hormone (AMH) level and expression in mural and cumulus cells in relation to age. J Ovarian Res 2014; 7: 113
• 43 Yu X, Li Z, Zhao X. et al. Anti-Müllerian hormone inhibits FSH-induced cumulus oocyte complex in vitro maturation and cumulus expansion in mice. Animals (Basel) 2022; 12 (09) 1209
• 44 Zhang Y, Shao L, Xu Y, Cui Y, Liu J, Chian RC. Effect of anti-Mullerian hormone in culture medium on quality of mouse oocytes matured in vitro. PLoS One 2014; 9 (06) e99393
• 45 Poole DH, Ocón-Grove OM, Johnson AL. Anti-Müllerian hormone (AMH) receptor type II expression and AMH activity in bovine granulosa cells. Theriogenology 2016; 86 (05) 1353-1360
• 46 Cheon KY, Chung YJ, Cho HH. et al. Expression of Müllerian-inhibiting substance/anti-Müllerian hormone type II receptor in the human theca cells. J Clin Endocrinol Metab 2018; 103 (09) 3376-3385
• 47 Chang HL, Pieretti-Vanmarcke R, Nicolaou F. et al. Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines. Gynecol Oncol 2011; 120 (01) 128-134
• 48 Yuan QA, Simmons HH, Robinson MK, Russeva M, Marasco WA, Adams GP. Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Mol Cancer Ther 2006; 5 (08) 2096-2105
• 49 Campbell BK, Clinton M, Webb R. The role of anti-Müllerian hormone (AMH) during follicle development in a monovulatory species (sheep). Endocrinology 2012; 153 (09) 4533-4543
• 50 Erickson GF, Shimasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 2003; 1: 9
• 51 Jin H, Won M, Park SE, Lee S, Park M, Bae J. FOXL2 is an essential activator of SF-1-induced transcriptional regulation of anti-Müllerian hormone in human granulosa cells. PLoS One 2016; 11 (07) e0159112
• 52 Watanabe K, Clarke TR, Lane AH, Wang X, Donahoe PK. Endogenous expression of Müllerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proc Natl Acad Sci U S A 2000; 97 (04) 1624-1629
• 53 Schteingart HF, Picard JY, Valeri C. et al. A mutation inactivating the distal SF1 binding site on the human anti-Müllerian hormone promoter causes persistent Müllerian duct syndrome. Hum Mol Genet 2019; 28 (19) 3211-3218
• 54 Rey R, Lukas-Croisier C, Lasala C, Bedecarrás P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003; 211 (1-2): 21-31
• 55 Pannetier M, Chassot AA, Chaboissier MC, Pailhoux E. Involvement of FOXL2 and RSPO1 in ovarian determination, development, and maintenance in mammals. Sex Dev 2016; 10 (04) 167-184
• 56 Park M, Suh DS, Lee K, Bae J. Positive cross talk between FOXL2 and AntiMüllerian hormone regulates ovarian reserve. Fertil Steril 2014; 102 (03) 847-855.e1
• 57 Prunskaite-Hyyryläinen R, Shan J, Railo A. et al. Wnt4, a pleiotropic signal for controlling cell polarity, basement membrane integrity, and antiMüllerian hormone expression during oocyte maturation in the female follicle. FASEB J 2014; 28 (04) 1568-1581
• 58 Roy S, Gandra D, Seger C. et al. Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3K27AC in granulosa cells. Endocrinology 2018; 159 (09) 3433-3445
• 59 Salmon NA, Handyside AH, Joyce IM. Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice. Dev Biol 2004; 266 (01) 201-208
• 60 Shi J, Yoshino O, Osuga Y. et al. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin beta subunits, and anti-Müllerian hormone in human granulosa cells. Fertil Steril 2009; 92 (05) 1794-1798
• 61 Convissar S, Armouti M, Fierro MA. et al. Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells. Reproduction 2017; 154 (06) 745-753
• 62 Wang L, Wang Y, Li B. et al. BMP6 regulates AMH expression via SMAD1/5/8 in goat ovarian granulosa cells. Theriogenology 2023; 197: 167-176
• 63 Devillers MM, Petit F, Cluzet V. et al. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol 2019; 240 (02) 215-228
• 64 Pierre A, Peigné M, Grynberg M. et al. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum Reprod 2013; 28 (03) 762-769
• 65 Umer S, Sammad A, Zou H. et al. Regulation of AMH, AMHR-II, and BMPs (2,6) genes of bovine granulosa cells treated with exogenous FSH and their association with protein hormones. Genes (Basel) 2019; 10 (12) 1038
• 66 Pellatt L, Hanna L, Brincat M. et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007; 92 (01) 240-245
• 67 Pierre A, Taieb J, Giton F. et al. Dysregulation of the anti-Müllerian hormone system by steroids in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017; 102 (11) 3970-3978
• 68 Kristensen SG, Kumar A, Kalra B. et al. Quantitative differences in TGF-β family members measured in small antral follicle fluids from women with or without PCO. J Clin Endocrinol Metab 2019; 104 (12) 6371-6384
• 69 Merhi Z, Buyuk E, Berger DS. et al. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Hum Reprod 2013; 28 (06) 1661-1669
• 70 Ding X, Kou X, Zhang Y, Zhang X, Cheng G, Jia T. Leptin siRNA promotes ovarian granulosa cell apoptosis and affects steroidogenesis by increasing NPY2 receptor expression. Gene 2017; 633: 28-34
• 71 Zhang BB, Li XN, Li MX, Sun YY, Shi YX, Ma TH. miR-140-3p promotes follicle granulosa cell proliferation and steroid hormone synthesis via targeting AMH in chickens. Theriogenology 2023; 202: 84-92
• 72 Qin C, Xia X, Fan Y. et al. A novel, noncoding-RNA-mediated, post-transcriptional mechanism of anti-Mullerian hormone regulation by the H19/let-7 axis. Biol Reprod 2019; 101 (01) 257
• 73 Durlinger AL, Kramer P, Karels B. et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999; 140 (12) 5789-5796
• 74 Guo R, Pankhurst MW. Accelerated ovarian reserve depletion in female anti-Müllerian hormone knockout mice has no effect on lifetime fertility. Biol Reprod 2020; 102 (04) 915-922
• 75 Yang MY, Cushman RA, Fortune JE. Anti-Müllerian hormone inhibits activation and growth of bovine ovarian follicles in vitro and is localized to growing follicles. Mol Hum Reprod 2017; 23 (05) 282-291
• 76 Kano M, Sosulski AE, Zhang L. et al. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A 2017; 114 (09) E1688-E1697
• 77 Kano M, Hsu JY, Saatcioglu HD. et al. Neoadjuvant treatment with Müllerian-inhibiting substance synchronizes follicles and enhances superovulation yield. J Endocr Soc 2019; 3 (11) 2123-2134
• 78 Li Y, Wei L, Meinsohn MC. et al. A screen of repurposed drugs identifies AMHR2/MISR2 agonists as potential contraceptives. Proc Natl Acad Sci U S A 2022; 119 (15) e2122512119
• 79 Vansandt LM, Meinsohn MC, Godin P. et al. Durable contraception in the female domestic cat using viral-vectored delivery of a feline anti-Müllerian hormone transgene. Nat Commun 2023; 14 (01) 3140
• 80 Zhao Y, Feng H, Zhang Y. et al. Current understandings of core pathways for the activation of mammalian primordial follicles. Cells 2021; 10 (06) 1491
• 81 Lecot-Connan T, Boumerdassi Y, Magnin F. et al. Anti-Müllerian hormone induces autophagy to preserve the primordial follicle pool in mice. FASEB J 2024; 38 (05) e23506
• 82 Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J 2019; 33 (01) 1278-1287
• 83 Ravikumar B, Sarkar S, Davies JE. et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010; 90 (04) 1383-1435
• 84 Zhao J, Brault JJ, Schild A. et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6 (06) 472-483
• 85 Rosario R, Stewart HL, Spears N, Telfer EE, Anderson RA. Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro. Hum Reprod 2024; 39 (02) 382-392
• 86 Visser JA, Durlinger AL, Peters IJ. et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology 2007; 148 (05) 2301-2308
• 87 Durlinger AL, Gruijters MJ, Kramer P. et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001; 142 (11) 4891-4899
• 88 Eilsø Nielsen M, Rasmussen IA, Fukuda M, Westergaard LG, Yding Andersen C. Concentrations of anti-Müllerian hormone in fluid from small human antral follicles show a negative correlation with CYP19 mRNA expression in the corresponding granulosa cells. Mol Hum Reprod 2010; 16 (09) 637-643
• 89 Grossman MP, Nakajima ST, Fallat ME, Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 2008; 89 (5, Suppl): 1364-1370
• 90 Jeppesen JV, Anderson RA, Kelsey TW. et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod 2013; 19 (08) 519-527
• 91 Hayes E, Kushnir V, Ma X. et al. Intra-cellular mechanism of Anti-Müllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol 2016; 433: 56-65
• 92 Sacchi S, D'Ippolito G, Sena P. et al. The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH. J Assist Reprod Genet 2016; 33 (01) 95-100
• 93 Xu J, Bishop CV, Lawson MS, Park BS, Xu F. Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates. Hum Reprod 2016; 31 (07) 1522-1530
• 94 Baba T, Ting AY, Tkachenko O, Xu J, Stouffer RL. Direct actions of androgen, estrogen and anti-Müllerian hormone on primate secondary follicle development in the absence of FSH in vitro. Hum Reprod 2017; 32 (12) 2456-2464
• 95 Rocha RMP, Lima LF, Brito IR. et al. Anti-Müllerian hormone reduces growth rate without altering follicular survival in isolated caprine preantral follicles cultured in vitro. Reprod Fertil Dev 2017; 29 (06) 1144-1154
• 96 Zhou Y, Richard S, Batchelor NJ, Oorschot DE, Anderson GM, Pankhurst MW. Anti-Müllerian hormone-mediated preantral follicle atresia is a key determinant of antral follicle count in mice. Hum Reprod 2022; 37 (11) 2635-2645
• 97 Cimino I, Casoni F, Liu X. et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 2016; 7: 10055
• 98 Chen M, Guo X, Zhong Y. et al. AMH inhibits androgen production in human theca cells. J Steroid Biochem Mol Biol 2023; 226: 106216
• 99 Picard JY, Josso N. Persistent Müllerian duct syndrome: an update. Reprod Fertil Dev 2019; 31 (07) 1240-1245
• 100 Gorsic LK, Dapas M, Legro RS, Hayes MG, Urbanek M. Functional genetic variation in the anti-Müllerian hormone pathway in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2019; 104 (07) 2855-2874
• 101 Gorsic LK, Kosova G, Werstein B. et al. Pathogenic anti-Müllerian hormone variants in polycystic ovary syndrome. J Clin Endocrinol Metab 2017; 102 (08) 2862-2872
• 102 Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS). Hum Reprod 2020; 35 (10) 2294-2302
• 103 Li L, Zhou X, Wang X. et al. A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Müllerian hormone signaling pathway. Mol Hum Reprod 2016; 22 (09) 669-678
• 104 Qin C, Yuan Z, Yao J, Zhu W, Wu W, Xie J. AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause. Reprod Biomed Online 2014; 29 (03) 311-318
• 105 Alvaro Mercadal B, Imbert R, Demeestere I. et al. AMH mutations with reduced in vitro bioactivity are related to premature ovarian insufficiency. Hum Reprod 2015; 30 (05) 1196-1202
• 106 Kevenaar ME, Themmen AP, Laven JS. et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum Reprod 2007; 22 (06) 1547-1554
• 107 Kevenaar ME, Themmen AP, Rivadeneira F. et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 2007; 22 (09) 2382-2388
• 108 Braem MG, Voorhuis M, van der Schouw YT. et al. Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause. PLoS One 2013; 8 (03) e59819
• 109 Voorhuis M, Broekmans FJ, Fauser BC, Onland-Moret NC, van der Schouw YT. Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab 2011; 96 (03) E473-E479
• 110 Yu ED, Zhu H, Li Y. et al. Polymorphisms of anti-Müllerian hormone signaling pathway in healthy Singapore women: population differences, endocrine effects and reproductive outcomes. Gynecol Endocrinol 2016; 32 (04) 311-314
• 111 Kevenaar ME, Laven JS, Fong SL. et al. A functional anti-Mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metab 2008; 93 (04) 1310-1316
• 112 Zheng MX, Li Y, Hu R, Wang FM, Zhang XM, Guan B. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance. J Assist Reprod Genet 2016; 33 (02) 199-205
• 113 Moolhuijsen LME, Louwers YV, McLuskey A. et al. Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients. Hum Reprod 2022; 37 (07) 1544-1556
• 114 Verdiesen RMG, van der Schouw YT, van Gils CH. et al. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. Hum Reprod 2022; 37 (05) 1069-1082
• 115 Ruth KS, Soares ALG, Borges MC. et al. Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan. Hum Mol Genet 2019; 28 (08) 1392-1401
• 116 Ruth KS, Day FR, Hussain J. et al; Biobank-based Integrative Omics Study (BIOS) Consortium, eQTLGen Consortium, Biobank Japan Project, China Kadoorie Biobank Collaborative Group, kConFab Investigators, LifeLines Cohort Study, InterAct consortium, 23andMe Research Team. Genetic insights into biological mechanisms governing human ovarian ageing. Nature 2021; 596 (7872) 393-397
• 117 Schuh-Huerta SM, Johnson NA, Rosen MP, Sternfeld B, Cedars MI, Reijo Pera RA. Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities. Hum Genet 2012; 131 (11) 1709-1724
• 118 Perry JR, McMahon G, Day FR, Ring SM, Nelson SM, Lawlor DA. Genome-wide association study identifies common and low-frequency variants at the AMH gene locus that strongly predict serum AMH levels in males. Hum Mol Genet 2016; 25 (02) 382-388